Information Library
Results for: Oncology - Product Development & Commercialization - Our Expertise
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Mapping the Future in Oncology Drug Development
White Paper — August 27, 2010
Industry veterans Harish Dave and Eric Groves summarize key findings of Quintiles’ ASCO Ancillary Event, Mapping the Future in Oncology Drug Development -
Mapping the Future in Oncology Drug Development
Hear from the Experts — March 29, 2010
A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development. -
Integration of Molecular Biomarkers into Clinical Development
White Paper — March 29, 2010
Examining the challenges and opportunities in co-developing a biomarker and drug, this is the first white paper in a new series focusing on oncology. -
Key Trends in Multiple Myeloma Treatment
White Paper — February 26, 2010
An overview of the latest studies into novel drug combinations and new therapies in early stage testing in multiple myeloma. -
Biomarker Trends in Breast Cancer Research
White Paper — February 24, 2010
Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies. -
Contracting Timeline
Case Study — March 27, 2009
Aggressive Recruitment Speeds Time to Market. The goal: to accelerate a study of a top-priority drug for non-myeloid malignancy. Quintiles ramped up 36 sites in just two months.
Page 1 of 1 (6 results)
